FDNA Inc. (http://www.fdna.com) and London Medical Databases Ltd. (http://www.lmdatabases.com) announced today that they have partnered to offer, for the first time, online access to the award winning database exclusively through FDNA's solutions.
FDNA, developer of the Facial Dysmorphology Novel Analysis technology, will fully integrate LMD's award-winning collection into Face2Gene[TM], the only available dysmorphology genetic search and reference solution, using facial analysis technology. Combining the power of Face2Gene's advanced facial dysmorphology analysis and phenotype search algorithms and of LMD's comprehensive collection of images and medical reference into one, simple to use and accessible solution provides a robust solution for the genetics professionals' community.
"We are delighted to have partnered with FDNA. FDNA's unique technology, innovative solutions and strong commitment to the community of genetics professionals made them a perfect partner to carry our life's work of curation into the new era of dysmorphology," said Dr. Michael Baraitser, Co-Author of LMD. "Making LMD available online is a long awaited need. FDNA's innovative technology adds unparalleled value to our existing and new customers. This unique combination allows users to access the most updated LMD version anytime, anywhere and easily search for the most relevant references," added Dr. Baraitser.
LMD has become, over the past 20 years, the gold-standard dysmorphology reference for genetics professionals. The databases include a superb collection of over 20,000 images, which show dysmorphic features and other relevant medical images associated with a multitude of genetic disorders.
"Integrating LMD into Face2Gene combines the world's first and only available computer-aided dysmorphology analysis solution with the most reputable dysmorphology database collection. The partnership places unparalleled power and convenience in the hands of thousands of medical professionals," said Dekel Gelbman, CEO of FDNA Inc. "We are honored to partner with LMD. This partnership further underscores our commitment to the genetics community. We plan to continue enhancing Face2Gene in many ways, making it better and more useful," added Mr. Gelbman.
Under this partnership, Dr. Baraitser will join FDNA's scientific advisory board headed by Dr. Michael R. Hayden and comprised of some of key opinion leaders in genetics, Including Dr. David A. Chitayat, Prof. Jill Clayton-Smith, Dr. Cynthia J.R. Curry, Prof. Dian Donnai, Dr. Sofia Douzgou, Dr. Karen W. Gripp, Dr. Judith G. Hall, Prof. Arnold Munnich, Prof. Motti Shohat, and Prof. Lina Vanagaite-Basel.
Study findings better define the genetic landscape of neuroendocrine tumors of the cervix